Cargando…

Cross-national comparative study of orphan drug policies in Saudi Arabia, the United States, and the European Union

BACKGROUND: Rare diseases are chronic, serious, and life-threatening conditions that have not received sufficient attention from drug developers due to their rarity. Policies have been implemented to encourage research and incentivize the development of orphan drugs. However, the implementation of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Balkhi, Bander, Almuaither, Asma, Alqahtani, Saeed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458326/ https://www.ncbi.nlm.nih.gov/pubmed/37638213 http://dx.doi.org/10.1016/j.jsps.2023.101738

Ejemplares similares

Colorectal cancer-related resource utilization and healthcare costs in Saudi Arabia
por: Balkhi, Bander, et al.
Publicado: (2023)

Exploring the value of a Doctor of Philosophy program in Pharmaceutical Outcomes and Policy Research in Saudi Arabia
por: AlRuthia, Yazed, et al.
Publicado: (2020)

The Economic Burden Associated with the Management of Different Stages of Breast Cancer: A Retrospective Cost of Illness Analysis in Saudi Arabia
por: Alghamdi, Ahmed, et al.
Publicado: (2021)

Predictors of orphan drug approval in the European Union
por: Heemstra, Harald E., et al.
Publicado: (2008)

Factors associated with glycemic control in type 2 diabetic patients in Saudi Arabia
por: Almetwazi, Mansour, et al.
Publicado: (2019)

Pharmacy students attitude and perception toward working in community pharmacy in Saudi Arabia
por: Balkhi, Bander, et al.
Publicado: (2020)

Healthcare Expenditures Associated with Heart Failure in Saudi Arabia: A Cost of Illness Study
por: Alghamdi, Ahmed, et al.
Publicado: (2021)

A retrospective study of real-world effectiveness and safety of rivaroxaban in patients with non-valvular atrial fibrillation and venous thromboembolism in Saudi Arabia
por: Alosaimi, Hind M., et al.
Publicado: (2022)

Use of biomarkers in the context of orphan medicines designation in the European Union
por: Tsigkos, Stelios, et al.
Publicado: (2014)

The patterns of children poisoning cases in community teaching hospital in Riyadh, Saudi Arabia
por: Alghadeer, Sultan, et al.
Publicado: (2018)

The burden of bites and stings management: Experience of an academic hospital in the Kingdom of Saudi Arabia
por: Khan, Anas, et al.
Publicado: (2020)

National medicines policy development, Saudi Arabia
por: Almoteiry, Khalid, et al.
Publicado: (2022)

Survival and Estimation of Direct Medical Costs of Hospitalized COVID-19 Patients in the Kingdom of Saudi Arabia (Short Title: COVID-19 Survival and Cost in Saudi Arabia)
por: Khan, Anas A., et al.
Publicado: (2020)

Establishing medical plausibility in the context of orphan medicines designation in the European Union
por: Tsigkos, Stelios, et al.
Publicado: (2014)

Evolving prevalence of haematological malignancies in orphan designation procedures in the European Union
por: Polsinelli, Benedetta, et al.
Publicado: (2017)

Pharmacy students’ attitudes toward patient safety in Saudi Arabia: a cross-sectional study
por: Alwhaibi, Monira, et al.
Publicado: (2020)

Cost-Effectiveness Analysis of Evolocumab for the Treatment of Dyslipidemia in the Kingdom of Saudi Arabia
por: Alghamdi, Ahmed, et al.
Publicado: (2021)

Policy-making in the European Union
por: Wallace, Helen, et al.
Publicado: (2015)

Comparing pharmaceutical pricing and reimbursement policies in Croatia to the European Union Member States
por: Vogler, Sabine, et al.
Publicado: (2011)

Erratum to: Establishing medical plausibility in the context of orphan medicines designation in the European Union
por: Tsigkos, Stelios, et al.
Publicado: (2015)

Oral antidiabetic medication adherence and glycaemic control among patients with type 2 diabetes mellitus: a cross-sectional retrospective study in a tertiary hospital in Saudi Arabia
por: Balkhi, Bander, et al.
Publicado: (2019)

Polypharmacy among patients with diabetes: a cross-sectional retrospective study in a tertiary hospital in Saudi Arabia
por: Alwhaibi, Monira, et al.
Publicado: (2018)

Demographic Characteristics and Status of Vaccinated Individuals with a History of COVID-19 Infection Pre- or Post-Vaccination: A Descriptive Study of a Nationally Representative Sample in Saudi Arabia
por: AlRuthia, Yazed, et al.
Publicado: (2022)

The State of Cardiac Rehabilitation in Saudi Arabia: Barriers, Facilitators, and Policy Implications
por: Adam, Tasneem, et al.
Publicado: (2023)

Drug utilization and cost associated with inflammatory bowel disease management in Saudi Arabia
por: AlRuthia, Yazed, et al.
Publicado: (2019)

Estimated Direct Medical Cost of Osteoporosis in Saudi Arabia: A Single-Center Retrospective Cost Analysis
por: Balkhi, Bander, et al.
Publicado: (2021)

Orphan disease status of cancer cachexia in the USA and in the European Union: a systematic review
por: Anker, Markus S., et al.
Publicado: (2019)

The Impact of COVID-19 on Essential Medicines and Personal Protective Equipment Availability and Prices in Saudi Arabia
por: Aljadeed, Rana, et al.
Publicado: (2021)

Policy-making in the European Union : conceptual lenses and the integration process /
por: Cram, Laura
Publicado: (1997)

A survey on the state of nanosafety research in the European Union and the United States
por: Duschl, Albert, et al.
Publicado: (2018)

Patient-reported outcome claims in European and United States orphan drug approvals
por: Jarosławski, Szymon, et al.
Publicado: (2018)

Assessing the pharmacy students’ knowledge of common medical terms after a curricular change in Saudi Arabia
por: AlRuthia, Yazed, et al.
Publicado: (2020)

The role of the European Union in health policies of member states – an example of the rare diseases policy in Croatia
por: Ivčić, Snježana, et al.
Publicado: (2021)

POSA2 Clinical Features and Management of COVID 19 in Saudi Arabia
por: Ezzi, A, et al.
Publicado: (2022)

Characteristics of Single Pivotal Trials Supporting Regulatory Approvals of Novel Non‐orphan, Non‐oncology Drugs in the European Union and United States from 2012−2016
por: Morant, Anne Vinther, et al.
Publicado: (2019)

Current status and vision of local pharmaceutical industries in Saudi Arabia: The focus on nanomedicines
por: Halwani, Abdulrahman A., et al.
Publicado: (2023)

Burnout and Depressive Symptoms in Healthcare Professionals: A Cross-Sectional Study in Saudi Arabia
por: Alwhaibi, Monira, et al.
Publicado: (2022)

Real-World Comparative Cost-Effectiveness Analysis of Different Classes of Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis in Saudi Arabia
por: AlRuthia, Yazed, et al.
Publicado: (2021)

Technology management and public policy in the European Union
por: Dankbaar, Ben, et al.
Publicado: (1996)

Internship preparedness among students in healthcare-related fields in the COVID-19 era: Exploring the attitude and knowledge in Saudi Arabia
por: Aldhahi, Monira, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_39lco3majabu8n93ionm9g6lev